...
首页> 外文期刊>Pharmaceuticals >Expanding the Concept of G Protein-Coupled Receptor (GPCR) Dimer Asymmetry towards GPCR-Interacting Proteins
【24h】

Expanding the Concept of G Protein-Coupled Receptor (GPCR) Dimer Asymmetry towards GPCR-Interacting Proteins

机译:将G蛋白偶联受体(GPCR)二聚体不对称概念扩展到与GPCR相互作用的蛋白

获取原文
           

摘要

G protein-coupled receptors (GPCRs), major targets of drug discovery, are organized in dimeric and/or oligomeric clusters. The minimal oligomeric unit, the dimer, is composed of two protomers, which can behave differently within the dimer. Several examples of GPCR asymmetry within dimers at the level of ligand binding, ligand-promoted conformational changes, conformational changes within transmembrane domains, G protein coupling, and most recently GPCR-interacting proteins (GIPs), have been reported in the literature. Asymmetric organization of GPCR dimers has important implications on GPCR function and drug design. Indeed, the extension of the “asymmetry concept” to GIPs adds a new level of specific therapeutic intervention.
机译:G蛋白偶联受体(GPCR)是药物发现的主要目标,组织为二聚体和/或寡聚体簇。最小的寡聚单元,即二聚体,由两个protomer组成,它们在二聚体中的行为可能不同。文献中已经报道了在二聚体内在配体结合,配体促进的构象变化,跨膜结构域内的构象变化,G蛋白偶联以及最近的GPCR相互作用蛋白(GIP)水平上的GPCR不对称的几个例子。 GPCR二聚体的不对称组织对GPCR功能和药物设计具有重要意义。实际上,将“不对称概念”扩展到GIP可以增加新水平的特异性治疗干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号